Award notice Supplies

Accord-cadre ayant pour objet la fourniture de Céfépime par voie injectable et de Ceftriaxone par voie injectable

Notice published in French. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Centrale de Négociation pour les Achats Hospitaliers
Erpent
Place of performance: 5101 Erpent
not published: buyer's address
Planned end of contract: 3 July 2028
likely re-tender around January 2028
Bids received: 1
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 3 January 2025
Notice language: French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Accord-cadre ayant pour objet la fourniture de Céfépime par voie injectable et de Ceftriaxone par voie injectable

Awarded to

Fresenius Kabi BCE/KBO 0458.813.760

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €269,390
Median: €449,863
A quarter above: €962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Accord-cadre ayant pour objet la fourniture de produits de contraste iodés et d'agents de diagnostic par résonance magnétique Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	GUERBET Bayer GE HEALTHCARE Bracco Imaging Europe	€42,237,307
Accord-cadre ayant pour objet la fourniture de Ceftriaxone Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	Fresenius Kabi	€960,210
Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	Viatris Grindeks Kalceks Belgium ACCORD HEALTHCARE	€761,230
Accord-cadre ayant pour objet la fourniture de Bosutinib Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	Pfizer	€3,061,220
Accord-cadre ayant pour objet la fourniture de Fingolimod 0,5 mg Centrale de Négociation pour les Achats Hospitaliers · 3 January 2025	Viatris	–

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 3548-2025.